Aganepag
Modify Date: 2024-09-18 01:12:38
Aganepag structure
|
Common Name | Aganepag | ||
|---|---|---|---|---|
| CAS Number | 910562-18-4 | Molecular Weight | 429.57200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H31NO4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AganepagAganepag is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. |
| Name | 5-[3-[(2S)-1-[4-[(1S)-1-hydroxyhexyl]phenyl]-5-oxopyrrolidin-2-yl]propyl]thiophene-2-carboxylic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. |
|---|---|
| Related Catalog | |
| Target |
EP2:0.19 nM (EC50) |
| In Vitro | Aganepag (Compound 3) is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention[1]. |
| References |
[1]. Robert M. Burk, et al. Compounds and methods for skin repair. WO2014078434A1 |
| Molecular Formula | C24H31NO4S |
|---|---|
| Molecular Weight | 429.57200 |
| Exact Mass | 429.19700 |
| PSA | 106.08000 |
| LogP | 5.64330 |
| unii-odt7zew9o7 |
| aganepag |